US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist
  • 16.7050
  • -0.2950-1.74%
Close Nov 6 16:00 ET
  • 16.7050
  • 0.00000.00%
Post 20:01 ET
22.05MMarket Cap-869P/E (TTM)

About Pieris Pharmaceuticals Company

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.

Company Profile

SymbolPIRS
Company NamePieris Pharmaceuticals
Listing DateJun 30, 2015
Issue Price3.12
Founded2001
CEOMr. Stephen S. Yoder
MarketNASDAQ
Employees50
Fiscal Year Ends12-31
Address225 Franklin Street,9th floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02109
Phone1-857-246-8998
Websitehttp://www.pieris.com

Company Executives

  • Name
  • Position
  • Salary
  • Stephen S. Yoder
  • Chief Executive Officer, President and Director
  • 1.36M
  • Thomas Bures
  • Principal Accounting Officer, Senior Vice President and Chief Financial Officer
  • 729.04K
  • James A. Geraghty
  • Chairman of the Board
  • 94.09K
  • Michael S. Richman
  • Independent Director
  • 52.09K
  • Christopher Kiritsy
  • Independent Director
  • 72.58K
  • Dr. Maya R. Said, Sc.D.
  • Independent Director
  • 52.09K
  • Dr. Matthew L. Sherman, M.D.
  • Independent Director
  • 53.09K
  • Dr. Peter A. Kiener, D.Phil.
  • Independent Director
  • 65.08K
  • Dr. Ann Barbier, M.D.,PhD
  • Independent Director
  • 52.09K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data